| Literature DB >> 22595447 |
Stella S Daskalopoulou1, Nadia A Khan, Robert R Quinn, Marcel Ruzicka, Donald W McKay, Daniel G Hackam, Simon W Rabkin, Doreen M Rabi, Richard E Gilbert, Raj S Padwal, Martin Dawes, Rhian M Touyz, Tavis S Campbell, Lyne Cloutier, Steven Grover, George Honos, Robert J Herman, Ernesto L Schiffrin, Peter Bolli, Thomas Wilson, Ross D Feldman, M Patrice Lindsay, Brenda R Hemmelgarn, Michael D Hill, Mark Gelfer, Kevin D Burns, Michel Vallée, G V Ramesh Prasad, Marcel Lebel, Donna McLean, J Malcolm O Arnold, Gordon W Moe, Jonathan G Howlett, Jean-Martin Boulanger, Pierre Larochelle, Lawrence A Leiter, Charlotte Jones, Richard I Ogilvie, Vincent Woo, Janusz Kaczorowski, Luc Trudeau, Simon L Bacon, Robert J Petrella, Alain Milot, James A Stone, Denis Drouin, Maxime Lamarre-Cliché, Marshall Godwin, Guy Tremblay, Pavel Hamet, George Fodor, S George Carruthers, George Pylypchuk, Ellen Burgess, Richard Lewanczuk, George K Dresser, Brian Penner, Robert A Hegele, Philip A McFarlane, Mukul Sharma, Norman R C Campbell, Debra Reid, Luc Poirier, Sheldon W Tobe.
Abstract
We updated the evidence-based recommendations for the diagnosis, assessment, prevention, and treatment of hypertension in adults for 2012. The new recommendations are: (1) use of home blood pressure monitoring to confirm a diagnosis of white coat syndrome; (2) mineralocorticoid receptor antagonists may be used in selected patients with hypertension and systolic heart failure; (3) a history of atrial fibrillation in patients with hypertension should not be a factor in deciding to prescribe an angiotensin-receptor blocker for the treatment of hypertension; and (4) the blood pressure target for patients with nondiabetic chronic kidney disease has now been changed to < 140/90 mm Hg from < 130/80 mm Hg. We also reviewed the recent evidence on blood pressure targets for patients with hypertension and diabetes and continue to recommend a blood pressure target of less than 130/80 mm Hg.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22595447 DOI: 10.1016/j.cjca.2012.02.018
Source DB: PubMed Journal: Can J Cardiol ISSN: 0828-282X Impact factor: 5.223